Man Group Portfolio holdings
AUM
$46.3B
1-Year Return
20.09%
This Quarter Return
+28.25%
1 Year Return
+20.09%
3 Year Return
+87.95%
5 Year Return
+152.77%
10 Year Return
–
AUM
$19.8B
AUM Growth
+$4.41B
(+29%)
Cap. Flow
+$171M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
16.82%
Holding
1,884
New
324
Increased
583
Reduced
656
Closed
225
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$223M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
Microsoft
MSFT
|
+$142M |
| 4 |
Bank of New York Mellon
BK
|
+$108M |
| 5 |
Dollar General
DG
|
+$98.3M |
Top Sells
| 1 |
Amazon
AMZN
|
+$145M |
| 2 |
Morgan Stanley
MS
|
+$107M |
| 3 |
IQVIA
IQV
|
+$72.6M |
| 4 |
Incyte
INCY
|
+$68.4M |
| 5 |
New Oriental
EDU
|
+$66M |
Sector Composition
| 1 | Technology | 24.34% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Financials | 12.46% |
| 5 | Consumer Staples | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Evolution Petroleum
EPM
$179M
| $421K | ﹤0.01% |
150,299
-9,638
| -6% | -$27K |
|
1427
Puma Biotechnology
PBYI
$229M
| $421K | ﹤0.01% |
40,334
+6,200
| +18% | +$64.7K |
|
1428
Collegium Pharmaceutical
COLL
$1.19B
| $419K | ﹤0.01% |
23,923
-8,508
| -26% | -$149K |
|
|
RCM
1429
DELISTED
R1 RCM Inc. Common Stock
RCM
| $419K | ﹤0.01% |
+37,600
| New | +$419K |
|
1430
Parker-Hannifin
PH
$96.9B
| $416K | ﹤0.01% |
2,272
+333
| +17% | +$61K |
|
|
UFS
1431
DELISTED
DOMTAR CORPORATION (New)
UFS
| $415K | ﹤0.01% |
19,678
-3,166
| -14% | -$66.8K |
|
1432
Tactile Systems Technology
TCMD
$296M
| $414K | ﹤0.01% |
+9,978
| New | +$414K |
|
1433
Carter's
CRI
$1.04B
| $411K | ﹤0.01% |
5,093
-40,299
| -89% | -$3.25M |
|
1434
Financial Institutions
FISI
$548M
| $411K | ﹤0.01% |
22,071
-1,600
| -7% | -$29.8K |
|
|
OPI
1435
Office Properties Income Trust
OPI
$18.7M
| $409K | ﹤0.01% |
15,754
+6,594
| +72% | +$171K |
|
1436
Cartesian Therapeutics
RNAC
$255M
| $407K | ﹤0.01% |
4,778
+3,491
| +271% | +$297K |
|
1437
iShares Core S&P 500 ETF
IVV
$670B
| $404K | ﹤0.01% |
+1,303
| New | +$404K |
|
1438
Tilly's
TLYS
$60M
| $397K | ﹤0.01% |
69,965
-5,725
| -8% | -$32.5K |
|
1439
MKS Inc. Common Stock
MKSI
$7.43B
| $393K | ﹤0.01% |
+3,471
| New | +$393K |
|
1440
SPDR S&P 500 ETF Trust
SPY
$664B
| $384K | ﹤0.01% |
+1,245
| New | +$384K |
|
1441
Purple Innovation
PRPL
$116M
| $383K | ﹤0.01% |
+21,300
| New | +$383K |
|
1442
Bunge Global
BG
$16.5B
| $379K | ﹤0.01% |
+9,216
| New | +$379K |
|
1443
Canadian Pacific Kansas City
CP
$68.4B
| $376K | ﹤0.01% |
7,370
-81,145
| -92% | -$4.14M |
|
1444
Sierra Bancorp
BSRR
$408M
| $375K | ﹤0.01% |
19,883
| – | – |
|
1445
Magnite
MGNI
$3.4B
| $375K | ﹤0.01% |
56,221
-4,991
| -8% | -$33.3K |
|
1446
Consumers Staples Select Sector SPDR Fund
XLP
$15.9B
| $375K | ﹤0.01% |
6,397
-7,992
| -56% | -$469K |
|
1447
iShares MSCI Hong Kong ETF
EWH
$728M
| $374K | ﹤0.01% |
17,482
-350
| -2% | -$7.49K |
|
|
ADAP
1448
Adaptimmune Therapeutics
ADAP
$13.5M
| $372K | ﹤0.01% |
37,155
+3,333
| +10% | +$33.4K |
|
1449
Caesars Entertainment
CZR
$5.33B
| $369K | ﹤0.01% |
9,202
-8,007
| -47% | -$321K |
|
1450
Interpublic Group of Companies
IPG
$9.51B
| $367K | ﹤0.01% |
21,374
-47,055
| -69% | -$808K |
|